Pancreatic Cancer Treatment Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, Italy, France, Spain, Italy, Russia, Poland, China, India, Japan, Australia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia), Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2017 – 2024
Report ID: GMI1941
Pancreatic Cancer Treatment Market size is projected to experience significant growth from 2017 to 2024.
Pancreatic cancer treatment market size should witness significant growth due to increasing healthcare expenditure, technological advancements and drug innovations coupled with huge number of unmet needs associated with the disease. Increased tobacco consumption, smoking, obesity and rising awareness levels regarding various treatment options should further drive the business size. Incidence rates of disease is mostly observed in the age group of 65 to 75 years. Therefore, rising geriatric population base are more prone to such disorder.
The National Pancreatic Cancer Foundation provide support for patients and families fighting against the disease. The National Comprehensive Cancer Network (NCCN), is a non-profile alliance of leading 27 cancer centers globally. The alliance provides books for patients on esophageal, lung, stomach and various other cancer types. Increased government initiatives to support and spread disease awareness should boost the therapy demand. High cost associated with the disease treatment, adverse side effects, and difficulty in diagnosis at initial stage are some of the factors restraining industry growth.
Pancreatic cancer is divided into two major types known as exocrine and endocrine tumors. About 95% of cases are exocrine. Its most common type is pancreatic ductal adenocarcinoma. The endocrine type is less prevalent, and still looking for effective treatment options. Hospitals should contribute for major revenue share over the forecast period. Increased disease treatment procedures in hospitals and growing number of patient visit should drive the segment growth.
Targeted therapy should contribute for significant revenue share over the forecast period. The growth is attributed to the development of innovative biologic therapies and targeted drugs in order to decrease the adverse effects of the ongoing therapy, such as chemotherapy. Targeted therapy attacks specific pathway or proteins involved in the growth of tumor cells. Researchers are working to develop novel targeted therapies which will drive pancreatic cancer treatment market growth over the forecast period.
In 2015, as per the National Center for Biotechnology Information, pancreatic cancer is one of the most severe malignancies and it is considered as the most common cause of cancer deaths in the U.S. The American Pancreatic Association (APA) is the association for doctors and researchers involved in exocrine pancreas disease. The aim of the association is to foster clinical and basic science research for the treatment of diseases. These factors should drive U.S. pancreatic cancer treatment market growth during the forecast timeframe.
In July 2015, Australasian Gastro?Intestinal Trials Group (AGITG) had organized Pancreatic Cancer Surgical Guidelines Workshop in collaboration with Avner Pancreatic Cancer Foundation. The Australian Pancreatic Cancer Genome Initiative (APGI) is the worldwide research initiative of more than 100 scientists, allied health professionals and clinicians engaged in research and care. Such associations should drive industry growth over the forecast period.
Some of the industry players are Eli Lilly and Company, Celgene, F. Hoffmann-La Roche, Novartis, Clovis Oncology, Amgen, Merck, Teva Pharmaceutical Industries, Pfizer and PharmaCyte Biotech. Partnerships, mergers and collaborations with established industry players are the major strategies adopted by the companies to gain revenue share.
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Why Global Market Insights?Comprehensive Research
- All-inclusive coverage
- In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
- Penetrative insights & latest trends
- Offers holistic understanding of the market
- Unique methodology
- Iterative in nature to eliminate errors
- Detailed methodology, scope, assumptions and data sources available for reference
- Committed to making a positive difference for our clients
- Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
- Every purchase comes with an option to obtain additional information:
- up to 10% of the original cost
- 45-minute analyst tele-call to obtain further clarity on the market.
- Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
- Only PCI-DSS compliant payment methods used for highest level of client data security
Connect with our sales team